NYSE: OMIOwens & Minor Inc Stock
$4.80+0.21 (+4.58%)
Updated Oct 17, 2025
OMI Price
$4.80
Fair Value Price
N/A
Market Cap
$370.77M
52 Week Low
$4.34
52 Week High
$15.54
P/E
-0.31x
P/B
-1.32x
P/S
0.08x
PEG
N/A
Dividend Yield
N/A
Revenue
$8.73B
Earnings
-$1.20B
Gross Margin
22.8%
Operating Margin
-12.44%
Profit Margin
-13.8%
Debt to Equity
-15.78
Operating Cash Flow
$101M
Beta
1.19
Next Earnings
Oct 29, 2025
Ex-Dividend
N/A
Next Dividend
N/A
OMI Overview
Owens & Minor, Inc. distributes consumable medical-surgical supplies to healthcare providers in the U.S. and internationally. Owens & Minor was founded in 1882 and is headquartered in Richmond, VA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine OMI's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Distribution
Industry Rating
A
OMI
Ranked#7 of 8
Ranked#7 of 8
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $786.00 | B | |
| $2.69 | B | |
| $156.41 | B |
Be the first to know about important OMI news, forecast changes, insider trades & much more!
OMI News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how OMI scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
OMI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
OMI is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
OMI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 35 more OMI due diligence checks available for Premium users.
Valuation
OMI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.31x
Industry
29.9x
Market
37.42x
OMI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-1.32x
Industry
321.92x
OMI's financial health
Profit margin
Revenue
$681.9M
Net Income
-$869.1M
Profit Margin
-127.4%
OMI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
OMI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.2B
Liabilities
$4.4B
Debt to equity
-15.78
OMI's short-term liabilities ($2.67B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OMI's short-term assets ($2.30B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OMI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
OMI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$37.6M
Investing
-$52.9M
Financing
$31.7M
OMI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
OMI vs Medical Distribution Stocks
Owens & Minor Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.